Can a common gut drug keep colorectal cancer at bay?

NCT ID NCT07405736

First seen Feb 12, 2026 · Last updated May 15, 2026 · Updated 16 times

Summary

This study tests whether adding lubiprostone, a drug used for constipation, to standard maintenance therapy can delay cancer recurrence in 124 adults with colorectal cancer that has spread to the lining of the abdomen. Participants have already had surgery to remove visible tumors and may have received heated chemotherapy inside the abdomen. The goal is to see if the combination improves the chance of staying cancer-free for at least one year compared to maintenance therapy alone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER (CRC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.